The Need

There are pockets of interest in benign RT, but there have been no international societies dedicated to the use of radiation for the treatment of benign conditions - until now.

The Need

Radiation Oncology is well served globally by ESTRO (European), ASTRO (US) and other national societies. ESTRO is focused on radiotherapy for cancer and state in their recent strategy document: “Whilst it is recognised that non-oncology indications for radiation therapy may expand with time, the formal inclusion of ‘‘oncology” in the vision statement highlights that the core indications for radiation therapy, hence the focus of our discipline, remain in oncology.” ASTRO also focuses on radiation oncology and cancer patients, and does not explicitly mention radiation for non-cancer conditions

The take-up for different conditions and in different countries is highly variable. There are a number of reasons for this, which include:

  • Lack of knowledge amongst radiation specialists. Additionally, the specialists are termed “radiation oncologists”, implicitly discouraging the use of RT for benign conditions

  • Nationally mandated allocation of radiotherapy resources to cancer

  • Fear of radiation-induced cancer

  • Growing numbers of alternative treatments for benign conditions

  • Lack of funding available for benign radiotherapy treatments in many healthcare systems

  • Lack of high-quality research in the field

  • Lack of a centralised group to educate and lobby for these treatments

This has resulted in:

  • A decline in the use of RT for benign conditions

  • A lack of knowledge and awareness about its use

  • A lack of support from public and private funding bodies for the treatment and funding of research into this area

  • A lack of training

  • A lack of publicly accessible publications

Find Out More

svgexport 5 1
The need for benign radiotherapy
svgexport 4 1
Find out more about the treatment
svgexport 6 1
Meet the team behind the IORBC